Contact Us
Pediatric Brain Tumors Global Market Report 2025
Global Pediatric Brain Tumors Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pediatric Brain Tumors Global Market Report 2025

By Type (Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, Choroid Plexus Papilloma Or Carcinoma, Tumors Arising From Non-Neuroepithelial Tissue, Meningeal Tumors), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy), By Diagnosis Method (Imaging Techniques, Biopsy, Neurological Exam, Lumbar Puncture), By Age Group (Infants, Toddlers, Children, Adolescents), By Application (Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pediatric Brain Tumors Market Overview

• Pediatric Brain Tumors market size has reached to $1.3 billion in 2024

• Expected to grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%

• Growth Driver: Impact Of Personalized Medicine On The Market Growth

• Market Trend: FDA Grants Accelerated Approval For Targeted Therapy In Pediatric Low-Grade Glioma Treatment

North America was the largest region in 2024.

What Is Covered Under Pediatric Brain Tumors Market?

Pediatric brain tumors are abnormal growths of cells in the brain or central nervous system (CNS) of children. These tumors can be benign (non-cancerous) or malignant (cancerous) and can originate in different parts of the brain or spinal cord. The goal of treatment is to shrink or remove the tumor, relieve symptoms, and preserve cognitive and motor functions, ensuring the child's long-term health and development.

The main types of pediatric brain tumors are gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma or carcinoma, and tumors arising from non-neuroepithelial tissue and meningeal tumors. Gliomas are the most common pediatric brain tumors, arising from glial cells and including subtypes varying in severity and requiring aggressive treatment due to their infiltrative growth and recurrence potential. It is cured by various treatment types, such as surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, with several diagnostic methods, including imaging techniques, biopsy, neurological exams, and lumbar puncture. It is found in various age groups, including infants, toddlers, children, and adolescents, and used in various applications such as hospitals and clinics, medical research centers, academic institutes, and others.

Pediatric Brain Tumors Market Size and growth rate 2025 to 2029: Graph

What Is The Pediatric Brain Tumors Market Size 2025 And Growth Rate?

The pediatric brain tumor market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the increasing incidence of pediatric brain tumors, emerging economies, growing investment in research and development, and growing demand for diagnostic technology, and the cases of pediatric tumors are increasing globally.

What Is The Pediatric Brain Tumors Market Growth Forecast?

The pediatric brain tumor market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to precision medicine, molecular profiling, targeted therapy, rising healthcare infrastructure, and extended insurance coverage. Major trends in the forecast period include the advancements in magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) scanning technologies, the use of genetic and molecular profiling, the development of targeted therapies, the introduction of immunotherapies, the rise of minimally invasive surgical techniques.

The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of precision pediatric neuro-oncology by inflating prices of MRI-guided laser ablation devices and targeted therapy drugs developed in Canada and Germany, resulting in delayed tumor resections and higher neurosurgical costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Pediatric Brain Tumors Market Segmented?

1) By Type: Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, Choroid Plexus Papilloma Or Carcinoma, Tumors Arising From Non-Neuroepithelial Tissue, Meningeal Tumors

2) By Treatment Type: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy

3) By Diagnosis Method: Imaging Techniques, Biopsy, Neurological Exam, Lumbar Puncture

4) By Age Group: Infants, Toddlers, Children, Adolescents

5) By Application: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other Applications

Subsegments:

1) By Gliomas: Low-Grade Gliomas, High-Grade Gliomas

2) By Mixed Neuronal-Glial Tumors: Gangliogliomas, Dysembryoplastic Neuroepithelial Tumors (DNET)

3) By Embryonal Tumors: Medulloblastoma, Atypical Teratoid Rhabdoid Tumor (ATRT), Primitive Neuroectodermal Tumors (PNET)

4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma, Choroid Plexus Carcinoma

5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma, Ewing's Sarcoma

6) By Meningeal Tumors: Meningiomas, Hemangiopericytomas

What Is Driving The Pediatric Brain Tumors Market? Impact Of Personalized Medicine On The Market Growth

The growing demand for personalized medicine is expected to propel the growth of the pediatric brain tumors market going forward. Personalized medicine is a healthcare strategy that customizes treatments and medical decisions according to a person's genetic makeup, lifestyle, and unique health requirements. The demand for personalized medicine rises due to advancements in genetic research, improved diagnostic tools, and the potential for more effective and targeted treatments. Personalized medicine enables targeted therapies that are more effective and cause less damage to healthy tissue by tailoring treatments to the child's specific tumor type, mutation, and response, it enhances outcomes and reduces side effects. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, growing demand for personalized medicine is driving the growth of the pediatric brain tumor industry.

Who Are The Major Players In The Global Pediatric Brain Tumors Market?

Major companies operating in the pediatric brain tumors market are AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., Seattle Children's Therapeutics

What Are The Key Trends Of The Global Pediatric Brain Tumors Market? FDA Grants Accelerated Approval For Targeted Therapy In Pediatric Low-Grade Glioma Treatment

Major companies operating in the pediatric brain tumors market are focusing on developing advanced treatments such as type II RAF inhibitors to enhance targeted therapies and improve patient outcomes. Type II RAF inhibitors are targeted therapies that focus on inhibiting RAF kinases, specifically those with mutations that drive tumor growth. These inhibitors are designed to target abnormal RAF protein structures found in certain pediatric low-grade glioma (pLGG) subtypes, effectively blocking the faulty signaling pathways that contribute to tumor cell proliferation and survival. For instance, in April 2024, Day One Biopharmaceuticals, a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for OJEMDA (tovorafenib) for the treatment of relapsed or refractory pediatric low-grade glioma (pLGG) in patients aged 6 months and older with specific BRAF alterations. This approval makes OJEMDA the first FDA-approved therapy targeting BRAF fusions or mutations in this patient population. The approval is based on the reported overall response rate of 51% from the FIREFLY-1 clinical trial, which assessed the drug's efficacy in this indication. It is specifically targeted towards children with brain tumor that has not responded to previous treatments.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Pediatric Brain Tumors Market? Ipsen Partnered With Day One Biopharmaceuticals To Commercialize Tovorafenib For Pediatric Low-Grade Glioma

In July 2024, Ipsen, a France-based biopharmaceutical company, partnered with Day One Biopharmaceuticals to commercialize tovorafenib for pediatric low-grade glioma (pLGG) outside of the United States. Through this collaboration, Ipsen will oversee regulatory and commercial activities for tovorafenib on a global scale. Day One Biopharmaceuticals is a US-based provider of treatment for childhood brain tumors such as OJEMDA.

What Is The Regional Outlook For The Global Pediatric Brain Tumors Market?

North America was the largest region in the pediatric brain tumors market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pediatric Brain Tumors  Market?

The pediatric brain tumor market consists of revenues earned by entities providing services such as neuro-oncology care, rehabilitation services, psychosocial support, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric brain tumor market also includes sales of chemotherapy drugs, surgical instruments, and radiation therapy equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pediatric Brain Tumors  Industry?

The pediatric brain tumors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric brain tumors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pediatric Brain Tumors Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.4 billion
Revenue Forecast In 2034 $1.81 billion
Growth Rate CAGR of 6.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The pediatric brain tumors market covered in this report is segmented –
1) By Type: Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, Choroid Plexus Papilloma Or Carcinoma, Tumors Arising From Non-Neuroepithelial Tissue, Meningeal Tumors
2) By Treatment Type: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy
3) By Diagnosis Method: Imaging Techniques, Biopsy, Neurological Exam, Lumbar Puncture
4) By Age Group: Infants, Toddlers, Children, Adolescents
5) By Application: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other Applications Subsegments:
1) By Gliomas: Low-Grade Gliomas, High-Grade Gliomas
2) By Mixed Neuronal-Glial Tumors: Gangliogliomas, Dysembryoplastic Neuroepithelial Tumors (DNET)
3) By Embryonal Tumors: Medulloblastoma, Atypical Teratoid Rhabdoid Tumor (ATRT), Primitive Neuroectodermal Tumors (PNET)
4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma, Choroid Plexus Carcinoma
5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma, Ewing's Sarcoma
6) By Meningeal Tumors: Meningiomas, Hemangiopericytomas
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., Seattle Children's Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Pediatric Brain Tumors Market Characteristics

3. Pediatric Brain Tumors Market Trends And Strategies

4. Pediatric Brain Tumors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pediatric Brain Tumors Growth Analysis And Strategic Analysis Framework

5.1. Global Pediatric Brain Tumors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pediatric Brain Tumors Market Growth Rate Analysis

5.4. Global Pediatric Brain Tumors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pediatric Brain Tumors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pediatric Brain Tumors Total Addressable Market (TAM)

6. Pediatric Brain Tumors Market Segmentation

6.1. Global Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gliomas

Mixed Neuronal-Glial Tumors

Embryonal Tumors

Choroid Plexus Papilloma Or Carcinoma

Tumors Arising From Non-Neuroepithelial Tissue

Meningeal Tumors

6.2. Global Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Radiation Therapy

Chemotherapy

Targeted Therapy

Immunotherapy

6.3. Global Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imaging Techniques

Biopsy

Neurological Exam

Lumbar Puncture

6.4. Global Pediatric Brain Tumors Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infants

Toddlers

Children

Adolescents

6.5. Global Pediatric Brain Tumors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Medical Research Centers

Academic Institutes

Other Applications

6.6. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Gliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low-Grade Gliomas

High-Grade Gliomas

6.7. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Mixed Neuronal-Glial Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gangliogliomas

Dysembryoplastic Neuroepithelial Tumors (DNET)

6.8. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Embryonal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medulloblastoma

Atypical Teratoid Rhabdoid Tumor (ATRT)

Primitive Neuroectodermal Tumors (PNET)

6.9. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Choroid Plexus Papilloma or Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Choroid Plexus Papilloma

Choroid Plexus Carcinoma

6.10. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Tumors Arising from Non-Neuroepithelial Tissue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rhabdomyosarcoma

Ewing's Sarcoma

6.11. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Meningeal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Meningiomas

Hemangiopericytomas

7. Pediatric Brain Tumors Market Regional And Country Analysis

7.1. Global Pediatric Brain Tumors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pediatric Brain Tumors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Brain Tumors Market

8.1. Asia-Pacific Pediatric Brain Tumors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Brain Tumors Market

9.1. China Pediatric Brain Tumors Market Overview

9.2. China Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Brain Tumors Market

10.1. India Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Brain Tumors Market

11.1. Japan Pediatric Brain Tumors Market Overview

11.2. Japan Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Brain Tumors Market

12.1. Australia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Brain Tumors Market

13.1. Indonesia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Brain Tumors Market

14.1. South Korea Pediatric Brain Tumors Market Overview

14.2. South Korea Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Brain Tumors Market

15.1. Western Europe Pediatric Brain Tumors Market Overview

15.2. Western Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Brain Tumors Market

16.1. UK Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Brain Tumors Market

17.1. Germany Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Brain Tumors Market

18.1. France Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Brain Tumors Market

19.1. Italy Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Brain Tumors Market

20.1. Spain Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Brain Tumors Market

21.1. Eastern Europe Pediatric Brain Tumors Market Overview

21.2. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Brain Tumors Market

22.1. Russia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Brain Tumors Market

23.1. North America Pediatric Brain Tumors Market Overview

23.2. North America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Brain Tumors Market

24.1. USA Pediatric Brain Tumors Market Overview

24.2. USA Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Brain Tumors Market

25.1. Canada Pediatric Brain Tumors Market Overview

25.2. Canada Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Brain Tumors Market

26.1. South America Pediatric Brain Tumors Market Overview

26.2. South America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Brain Tumors Market

27.1. Brazil Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Brain Tumors Market

28.1. Middle East Pediatric Brain Tumors Market Overview

28.2. Middle East Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Brain Tumors Market

29.1. Africa Pediatric Brain Tumors Market Overview

29.2. Africa Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Brain Tumors Market Competitive Landscape And Company Profiles

30.1. Pediatric Brain Tumors Market Competitive Landscape

30.2. Pediatric Brain Tumors Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Brain Tumors Market Other Major And Innovative Companies

31.1. UCLA Health

31.2. Ipsen Pharma

31.3. Novocure

31.4. Blueprint Medicines

31.5. Karyopharm Therapeutics Inc.

31.6. Renaissance Pharma

31.7. Servier Laboratories

31.8. Matica Biotechnology

31.9. Curis Inc.

31.10. Oncoheroes Biosciences

31.11. Treovir Inc.

31.12. Plus Therapeutics Inc.

31.13. Stemline Therapeutics Inc.

31.14. BrainChild Bio Inc.

31.15. Seattle Children's Therapeutics

32. Global Pediatric Brain Tumors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Brain Tumors Market

34. Recent Developments In The Pediatric Brain Tumors Market

35. Pediatric Brain Tumors Market High Potential Countries, Segments and Strategies

35.1 Pediatric Brain Tumors Market In 2029 - Countries Offering Most New Opportunities

35.2 Pediatric Brain Tumors Market In 2029 - Segments Offering Most New Opportunities

35.3 Pediatric Brain Tumors Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pediatric Brain Tumors Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pediatric Brain Tumors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Gliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Mixed Neuronal-Glial Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Embryonal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Choroid Plexus Papilloma or Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Tumors Arising from Non-Neuroepithelial Tissue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Meningeal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Pediatric Brain Tumors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Pediatric Brain Tumors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: AbbVie Inc. Financial Performance
  • Table 83: Bayer AG Financial Performance
  • Table 84: Novartis AG Financial Performance
  • Table 85: Roche Holding AG Financial Performance
  • Table 86: Takeda Pharmaceutical Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pediatric Brain Tumors Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pediatric Brain Tumors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Gliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Mixed Neuronal-Glial Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Embryonal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Choroid Plexus Papilloma or Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Tumors Arising from Non-Neuroepithelial Tissue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Pediatric Brain Tumors Market, Sub-Segmentation Of Meningeal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Pediatric Brain Tumors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Pediatric Brain Tumors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: AbbVie Inc. Financial Performance
  • Figure 83: Bayer AG Financial Performance
  • Figure 84: Novartis AG Financial Performance
  • Figure 85: Roche Holding AG Financial Performance
  • Figure 86: Takeda Pharmaceutical Company Financial Performance

Frequently Asked Questions

Pediatric brain tumors are abnormal growths of cells in the brain or central nervous system (CNS) of children. These tumors can be benign (non-cancerous) or malignant (cancerous) and can originate in different parts of the brain or spinal cord. The goal of treatment is to shrink or remove the tumor, relieve symptoms, and preserve cognitive and motor functions, ensuring the child's long-term health and development. For further insights on this market, request a sample here

The market major growth driver - Impact Of Personalized Medicine On The Market Growth. For further insights on this market, request a sample here

The pediatric brain tumors market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the increasing incidence of pediatric brain tumors, emerging economies, growing investment in research and development, and growing demand for diagnostic technology, and the cases of pediatric tumors are increasing globally. The pediatric brain tumors market size is expected to see strong growth in the next few years. It will grow to " $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to precision medicine, molecular profiling, targeted therapy, rising healthcare infrastructure, and extended insurance coverage. Major trends in the forecast period include the advancements in magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) scanning technologies, the use of genetic and molecular profiling, the development of targeted therapies, the introduction of immunotherapies, the rise of minimally invasive surgical techniques. For further insights on this market, request a sample here

The pediatric brain tumorsmarket covered in this report is segmented –
1) By Type: Gliomas; Mixed Neuronal-Glial Tumors; Embryonal Tumors; Choroid Plexus Papilloma Or Carcinoma; Tumors Arising From Non-Neuroepithelial Tissue; Meningeal Tumors
2) By Treatment Type: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy
3) By Diagnosis Method: Imaging Techniques; Biopsy; Neurological Exam; Lumbar Puncture
4) By Age Group: Infants; Toddlers; Children; Adolescents
5) By Application: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other Applications Subsegments:
1) By Gliomas: Low-Grade Gliomas; High-Grade Gliomas
2) By Mixed Neuronal-Glial Tumors: Gangliogliomas; Dysembryoplastic Neuroepithelial Tumors (DNET)
3) By Embryonal Tumors: Medulloblastoma; Atypical Teratoid Rhabdoid Tumor (ATRT); Primitive Neuroectodermal Tumors (PNET)
4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma; Choroid Plexus Carcinoma
5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma; Ewing's Sarcoma
6) By Meningeal Tumors: Meningiomas; Hemangiopericytomas For further insights on this market,
request a sample here

North America was the largest region in the pediatric brain tumors market in 2024. The regions covered in the pediatric brain tumors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the pediatric brain tumors market are AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., Seattle Children's Therapeutics . For further insights on this market, request a sample here.

Major trends in this market include FDA Grants Accelerated Approval For Targeted Therapy In Pediatric Low-Grade Glioma Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon